Ligand validation:7OOE

AN2: AMP PHOSPHORAMIDATE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7OOE_AN2_A_503	98%	17%	0.055	0.976	2.13	1.49	3	5	2	0	100%	1
7OOE_AN2_B_502	75%	19%	0.088	0.921	2.23	1.28	4	3	0	0	100%	1
7P31_AN2_A_1002	97%	21%	0.058	0.973	1.91	1.43	3	5	1	0	100%	1
7OOG_AN2_A_503	97%	18%	0.059	0.972	2.02	1.53	2	3	2	0	100%	1
7NQR_AN2_B_503	88%	15%	0.103	0.978	2.28	1.48	4	4	0	0	100%	1
7NQU_AN2_B_502	81%	15%	0.111	0.963	2.34	1.49	4	3	0	0	100%	1
7NQZ_AN2_B_502	80%	15%	0.121	0.971	2.42	1.4	4	3	2	0	100%	1
6GR3_AN2_A_301	96%	10%	0.069	0.98	2.41	1.99	4	6	1	0	100%	1
5JZJ_AN2_B_902	96%	14%	0.069	0.979	2	1.85	7	3	1	0	100%	1
5C3Y_AN2_H_401	90%	10%	0.103	0.985	2.64	1.67	6	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.